Cargando…

MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumors: MEN1 promotes ferroptosis in pancreatic neuroendocrine tumors

Pancreatic neuroendocrine tumor (pNET) is the second most common malignant tumors of the pancreas. Multiple endocrine neoplasia 1 ( MEN1) is the most frequently mutated gene in pNETs and MEN1-encoded protein, menin, is a scaffold protein that interacts with transcription factors and chromatin-modify...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Zeng, Chen, Haidi, Ji, Shunrong, Hu, Yuheng, Lou, Xin, Zhang, Wuhu, Jing, Desheng, Fan, Guixiong, Zhang, Yue, Chen, Xuemin, Zhuo, Qifeng, Chen, Jie, Xu, Xiaowu, Yu, Xianjun, Xu, Jin, Qin, Yi, Gao, Heli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828289/ https://www.ncbi.nlm.nih.gov/pubmed/36604142 http://dx.doi.org/10.3724/abbs.2022162

Ejemplares similares

FBW7-NRA41-SCD1 axis synchronously regulates apoptosis and ferroptosis in pancreatic cancer cells
por: Ye, Zeng, et al.
Publicado: (2020)

Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment
por: Xu, Junfeng, et al.
Publicado: (2023)

Value of lymphadenectomy in patients with surgically resected pancreatic neuroendocrine tumors
por: Zhang, Zheng, et al.
Publicado: (2022)

Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy
por: Hu, Yuheng, et al.
Publicado: (2021)

Orlistat Induces Ferroptosis in Pancreatic Neuroendocrine Tumors by Inactivating the MAPK Pathway
por: Ye, Mujie, et al.
Publicado: (2023)

Prognostic Significance of Altered ATRX/DAXX Gene in Pancreatic Neuroendocrine Tumors: A Meta-Analysis
por: Wang, Fei, et al.
Publicado: (2021)

Expression of transcription factors in MEN1-associated pancreatic neuroendocrine tumors
por: Takeda, Yasutaka, et al.
Publicado: (2017)

SETD8 inhibits ferroptosis in pancreatic cancer by inhibiting the expression of RRAD
por: Lu, Zekun, et al.
Publicado: (2023)

Ferroptosis: Final destination for cancer?
por: Ye, Zeng, et al.
Publicado: (2020)

Minimally invasive enucleation of pancreatic tumors: The main pancreatic duct is no longer a restricted area
por: Li, Zheng, et al.
Publicado: (2023)

The Interplay of Four Main Pathways Recomposes Immune Landscape in Primary and Metastatic Gastroenteropancreatic Neuroendocrine Tumors
por: Lou, Xin, et al.
Publicado: (2022)

ALDOA inhibits cell cycle arrest induced by DNA damage via the ATM-PLK1 pathway in pancreatic cancer cells
por: Chen, Haidi, et al.
Publicado: (2021)

DAXX/ATRX and MEN1 genes are strong prognostic markers in pancreatic neuroendocrine tumors
por: Park, Joo Kyung, et al.
Publicado: (2017)

Pancreatic Neuroendocrine Tumors in MEN1 Patients: Difference in Post-Operative Complications and Tumor Progression between Major and Minimal Pancreatic Surgeries
por: Tonelli, Francesco, et al.
Publicado: (2023)

Pin1 promotes pancreatic cancer progression and metastasis by activation of NF‐κB‐IL‐18 feedback loop
por: Sun, Qiqing, et al.
Publicado: (2020)

Late onset asymptomatic pancreatic neuroendocrine tumor – A case report on the phenotypic expansion for MEN1
por: Kaiwar, Charu, et al.
Publicado: (2017)

GHRH secretion from a pancreatic neuroendocrine tumor causing gigantism in a patient with MEN1
por: Srirangam Nadhamuni, Vinaya, et al.
Publicado: (2021)

SCD1 deficiency exacerbates osteoarthritis by inducing ferroptosis in chondrocytes
por: Yu, Chao, et al.
Publicado: (2023)

ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup
por: Chan, Chang S., et al.
Publicado: (2018)

Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome
por: Koivikko, Minna, et al.
Publicado: (2022)

A Novel Pathogenic MEN1 Gene Variant Identified in a Family With Multiple Pancreatic Neuroendocrine Tumors
por: Horikoshi, Hirofumi, et al.
Publicado: (2023)

Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer
por: Zhang, Zheng, et al.
Publicado: (2021)

Diagnosis of Pancreatic Neuroendocrine Tumors
por: Lee, Dong Wook, et al.
Publicado: (2017)

Pancreatic paraganglioma mimicking pancreatic neuroendocrine tumor
por: Abbasi, Arezou, et al.
Publicado: (2020)

Nodal promotes colorectal cancer survival and metastasis through regulating SCD1-mediated ferroptosis resistance
por: Wu, Tianqi, et al.
Publicado: (2023)

GOT1 inhibition promotes pancreatic cancer cell death by ferroptosis
por: Kremer, Daniel M., et al.
Publicado: (2021)

THU511 Somatostatin Analogs Or Active Surveillance In Sporadic And MEN1 Associated Non-functioning Pancreatic Neuroendocrine Tumors
por: Raia, Salvatore, et al.
Publicado: (2023)

Glutamine deprivation induces ferroptosis in pancreatic cancer cells: Glutamine deprivation induces pancreatic cancer ferroptosis
por: Xiao, Zhiwen, et al.
Publicado: (2023)

A MEN1 pancreatic neuroendocrine tumour mouse model under temporal control
por: Lines, K E, et al.
Publicado: (2017)

Multimodal Management of Grade 1 and 2 Pancreatic Neuroendocrine Tumors
por: Marchese, Ugo, et al.
Publicado: (2022)

Bone Loss in Patients with Pancreatic Neuroendocrine Tumors
por: Tong, He, et al.
Publicado: (2022)

Concurrent Mutations in STK11 and KEAP1 Promote Ferroptosis Protection and SCD1 Dependence in Lung Cancer
por: Wohlhieter, Corrin A., et al.
Publicado: (2020)

Ferroptosis Suppressor Protein 1 Inhibition Promotes Tumor Ferroptosis and Anti-tumor Immune Responses in Liver Cancer
por: Cheu, Jacinth Wing-Sum, et al.
Publicado: (2023)

Molecular Pathogenesis of Pancreatic Neuroendocrine Tumors
por: Ehehalt, Florian, et al.
Publicado: (2010)

PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
por: BELOTTO, Marcos, et al.
Publicado: (2019)

Treatment Options for Pancreatic Neuroendocrine Tumors
por: Akirov, Amit, et al.
Publicado: (2019)

Surgical Management of Pancreatic Neuroendocrine Tumors
por: Sulciner, Megan L., et al.
Publicado: (2023)

Simultaneous EUS-FNA Diagnosis and TNM Staging of a Pancreatic Neuroendocrine Tumor in a Patient with an Unrecognized MEN Type 1
por: Ferrara, Francesco, et al.
Publicado: (2012)

Octreotide Use in a Patient with MEN-1 Syndrome and Multifocal Pancreatic Neuroendocrine Tumors: A Case Report and Review of the Literature
por: Kemm, Matthew H., et al.
Publicado: (2019)

Somatostatin Analogue Therapy in MEN1-Related Pancreatic Neuroendocrine Tumors from Evidence to Clinical Practice: A Systematic Review
por: La Salvia, Anna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4q2aehpg7rfp9lkg6gob2eke3b